Timothy Hatlen to Antibodies, Neutralizing
This is a "connection" page, showing publications Timothy Hatlen has written about Antibodies, Neutralizing.
Connection Strength
0.340
-
Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment. PLoS One. 2025; 20(6):e0325561.
Score: 0.231
-
SARS-Cov-2 vaccination strategies in hospitalized recovered COVID-19 patients: a randomized clinical trial (VATICO Trial). Sci Rep. 2025 Mar 22; 15(1):9882.
Score: 0.057
-
Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19. J Infect Dis. 2024 03 14; 229(3):671-679.
Score: 0.053